ATRC as reported
AtriCure, Inc. reported $552M of revenue over the trailing twelve months, +15% on the year before. 11 reported series are charted on this page, each one as filed.
$552M
Revenue, trailing twelve months · to Q1 2026 · +15% against the twelve months before
- Net Income
- −$4.6M
Net Income · −88% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $54M
Free Cash Flow · +374% year on year · trailing twelve months to Q1 2026
- Op Margin
- −0.56%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $552M | +15% | Q1 2026 |
| Net Income | −$4.6M | −88% | Q1 2026 |
| EPS | −$0.10 | −88% | Q1 2026 |
| Gross Margin | 76% | n/a | Q1 2026 |
| Op Margin | −0.56% | n/a | Q1 2026 |
| Net Margin | −0.85% | n/a | Q1 2026 |
| ROE | −4.3% | n/a | Q1 2026 |
| ROA | −3.2% | n/a | Q1 2026 |
| ROIC | −3.6% | n/a | Q1 2026 |
| Free Cash Flow | $54M | +374% | Q1 2026 |
| P/E | 58.2 | n/a | Q2 2022 · 15 quarters behind |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
AtriCure, Inc. (ATRC) - Revenue & ProfitRevenue & ProfitAtriCure, Inc. (ATRC)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #10 of 27 by Smart Score